MCID: EXT010
MIFTS: 52

Extramedullary Plasmacytoma

Categories: Cancer diseases, Immune diseases, Blood diseases

Aliases & Classifications for Extramedullary Plasmacytoma

MalaCards integrated aliases for Extramedullary Plasmacytoma:

Name: Extramedullary Plasmacytoma 12 14 69
Plasmacytoma, Extramedullary 12
Extraosseous Plasmacytoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3720
ICD10 32 C90.2 C90.20
NCIt 46 C4002
UMLS 69 C0278619

Summaries for Extramedullary Plasmacytoma

MalaCards based summary : Extramedullary Plasmacytoma, also known as plasmacytoma, extramedullary, is related to plasmacytoma and myeloma, multiple. An important gene associated with Extramedullary Plasmacytoma is B2M (Beta-2-Microglobulin), and among its related pathways/superpathways are Innate Immune System and Akt Signaling. The drugs Bortezomib and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and colon, and related phenotypes are cardiovascular system and cellular

Related Diseases for Extramedullary Plasmacytoma

Diseases related to Extramedullary Plasmacytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 126)
# Related Disease Score Top Affiliating Genes
1 plasmacytoma 31.5 B2M IGKC IL2 IL6
2 myeloma, multiple 30.6 B2M CCND1 IL6
3 tonsillitis 30.3 IL2 IL6
4 marginal zone b-cell lymphoma 29.6 BCL2 CCND1
5 lymphoma, mucosa-associated lymphoid type 29.4 BCL2 CCND1 IGKC
6 leukemia, chronic lymphocytic 28.7 B2M BCL2 CCND1 IL2
7 thyroiditis 10.4
8 extramedullary soft tissue plasmacytoma 10.2
9 monoclonal gammopathy of uncertain significance 10.2 B2M IL6
10 post-transplant lymphoproliferative disease 10.2 B2M IL6
11 plasma cell neoplasm 10.2 B2M IL6
12 lymphoma 10.2
13 hemorrhagic fever with renal syndrome 10.2 B2M IL6
14 meningoencephalitis 10.1 B2M IL6
15 b-cell expansion with nfkb and t-cell anergy 10.1 B2M IL2
16 streptococcal toxic-shock syndrome 10.1 IL2 IL6
17 immune suppression 10.1 IL2 IL6
18 uremic pruritus 10.1 IL2 IL6
19 capillary leak syndrome 10.1 IL2 IL6
20 vernal conjunctivitis 10.1 B2M IL2
21 microscopic colitis 10.1 IL2 IL6
22 mediastinitis 10.1
23 burning mouth syndrome 10.1 IL2 IL6
24 necrotizing fasciitis 10.1 IL2 IL6
25 intermediate uveitis 10.1 IL2 IL6
26 hematopoietic stem cell transplantation 10.1 IL2 IL6
27 commensal bacterial infectious disease 10.1 IL2 IL6
28 sinusitis 10.1
29 nasopharyngitis 10.1
30 cervicitis 10.1
31 pancreatitis 10.1
32 amyloidosis 10.1
33 retroperitoneal neuroblastoma 10.1 CDKN1A IL2
34 retinal cancer 10.1 CCND1 CDKN1A
35 carpal tunnel syndrome 10.1 B2M IL6
36 sensory system cancer 10.1 CCND1 CDKN1A
37 paracoccidioidomycosis 10.0 IL2 IL6
38 lymphoma, small cleaved-cell, diffuse 10.0 BCL2 CCND1
39 adenocarcinoma 10.0
40 brucellosis 10.0 IL2 IL6
41 intravascular large b-cell lymphoma 10.0 B2M BCL2
42 tongue cancer 10.0 CCND1 CDKN1A
43 tropical spastic paraparesis 10.0 IL2 IL6
44 hidradenocarcinoma 10.0 BCL2 CCND1
45 keratocystic odontogenic tumor 10.0 BCL2 CCND1
46 salivary gland adenoid cystic carcinoma 10.0 BCL2 CCND1
47 spondyloarthropathy 9.9 IL2 IL6
48 intussusception 9.9
49 pancreatic cancer 9.9
50 meningioma, familial 9.9

Graphical network of the top 20 diseases related to Extramedullary Plasmacytoma:



Diseases related to Extramedullary Plasmacytoma

Symptoms & Phenotypes for Extramedullary Plasmacytoma

MGI Mouse Phenotypes related to Extramedullary Plasmacytoma:

43
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.95 CCND1 IL6 B2M CDKN1A BCL2 IL2
2 cellular MP:0005384 9.93 IL6 BCL2 IL2 CCND1 B2M CDKN1A
3 digestive/alimentary MP:0005381 9.91 CCND1 IL6 B2M CDKN1A BCL2 IL2
4 endocrine/exocrine gland MP:0005379 9.88 CCND1 IL6 B2M CDKN1A BCL2 IL2
5 hematopoietic system MP:0005397 9.85 CCND1 IL6 B2M CDKN1A BCL2 IL2
6 immune system MP:0005387 9.8 IL6 BCL2 IL2 CCND1 B2M CDKN1A
7 integument MP:0010771 9.65 CCND1 IL6 B2M CDKN1A BCL2
8 neoplasm MP:0002006 9.63 CCND1 IL6 B2M CDKN1A BCL2 IL2
9 reproductive system MP:0005389 9.43 CCND1 IL6 B2M CDKN1A BCL2 IL2
10 vision/eye MP:0005391 9.02 CCND1 IL6 CDKN1A BCL2 IL2

Drugs & Therapeutics for Extramedullary Plasmacytoma

Drugs for Extramedullary Plasmacytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 220)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bortezomib Approved, Investigational Phase 3,Phase 2,Phase 1 179324-69-7 387447 93860
2
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
3
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2 50-02-2 5743
4
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
5
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
6
Darbepoetin alfa Approved, Investigational Phase 3,Phase 2 209810-58-2, 11096-26-7
7
Iron Approved Phase 3,Phase 1,Phase 2 7439-89-6 23925
8
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
9
Dalteparin Approved Phase 3 9005-49-6
10
Heparin Approved, Investigational Phase 3 9005-49-6 46507594 772
11
Ondansetron Approved Phase 3 99614-02-5 4595
12
Amphotericin B Approved, Investigational Phase 3 1397-89-3 5280965 14956
13
Caspofungin Approved Phase 3,Phase 2 162808-62-0, 179463-17-3 2826718 468682
14
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2 22916-47-8 4189
15
Dextromethorphan Approved Phase 3 125-71-3 5362449 5360696
16
Guaifenesin Approved, Investigational, Vet_approved Phase 3 93-14-1 3516
17
Morphine Approved, Investigational Phase 3 57-27-2 5288826
18
Ginseng Approved, Investigational, Nutraceutical Phase 3 50647-08-0
19
St. John's Wort Approved, Investigational, Nutraceutical Phase 3 84082-80-4
20
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
21 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
22 Alkylating Agents Phase 3,Phase 2,Phase 1
23 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
24 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1
25 Antiemetics Phase 3,Phase 2,Phase 1
26 Anti-Inflammatory Agents Phase 3,Phase 2,Phase 1
27 Antineoplastic Agents, Hormonal Phase 3,Phase 2,Phase 1
28 Antirheumatic Agents Phase 3,Phase 2,Phase 1
29 Autonomic Agents Phase 3,Phase 2,Phase 1
30 BB 1101 Phase 3,Phase 2
31 Dexamethasone acetate Phase 3,Phase 2 1177-87-3
32 Gastrointestinal Agents Phase 3,Phase 2,Phase 1
33 glucocorticoids Phase 3,Phase 2,Phase 1
34 HIV Protease Inhibitors Phase 3,Phase 2,Phase 1
35 Hormone Antagonists Phase 3,Phase 2,Phase 1
36 Hormones Phase 3,Phase 2,Phase 1
37 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1
38 Immunosuppressive Agents Phase 3,Phase 2,Phase 1
39 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1
40
protease inhibitors Phase 3,Phase 2,Phase 1
41 Proteasome Inhibitors Phase 3,Phase 1
42 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
43 Analgesics Phase 3
44 Anesthetics Phase 3
45 Anesthetics, Dissociative Phase 3
46 Anesthetics, General Phase 3
47 Anesthetics, Intravenous Phase 3
48 Central Nervous System Depressants Phase 3,Phase 1,Phase 2
49 Excitatory Amino Acid Antagonists Phase 3
50 Excitatory Amino Acids Phase 3

Interventional clinical trials:

(show top 50) (show all 68)

# Name Status NCT ID Phase Drugs
1 CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma Unknown status NCT02336386 Phase 3 CDD;CDD Plus Bortezomib
2 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
3 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
4 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
5 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
6 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
7 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
8 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
9 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
10 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
11 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
12 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
13 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
14 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
15 Beta Alethine in Treating Patients With Myeloma Unknown status NCT00006466 Phase 1, Phase 2 beta alethine
16 Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00489203 Phase 2 beclomethasone dipropionate;placebo;tacrolimus;methotrexate
17 Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy Completed NCT00416624 Phase 2 darbepoetin alfa;epoetin alfa
18 SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant Completed NCT00002657 Phase 2 cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;methotrexate;prednisone;vincristine sulfate
19 Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer Completed NCT00823524 Phase 1, Phase 2
20 Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer Completed NCT00255749 Phase 2
21 Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer Completed NCT00002504 Phase 2
22 Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00245037 Phase 1, Phase 2 busulfan;cyclosporine;fludarabine phosphate;mycophenolate mofetil;Granulocyte colony-stimulating factor (G-CSF);Phenytoin;Methotrexate
23 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer Completed NCT00003406 Phase 1, Phase 2 carboplatin;docetaxel;ifosfamide
24 Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant Completed NCT00110045 Phase 2 caspofungin acetate
25 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
26 Non-Ablative Allo HSCT For Hematologic Malignancies or SAA Completed NCT00006379 Phase 2 cyclophosphamide;fludarabine phosphate
27 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00005804 Phase 2 cyclophosphamide
28 Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer Completed NCT00006225 Phase 1, Phase 2
29 Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation Completed NCT00005606 Phase 2
30 Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia Recruiting NCT02547662 Phase 2 Dexamethasone;Ixazomib Citrate;Pomalidomide
31 Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow Recruiting NCT00003838 Phase 2
32 Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma Active, not recruiting NCT01849783 Phase 2 dexamethasone;cisplatin;doxorubicin;cyclophosphamide;etoposide;bortezomib;thalidomide;melphalan
33 S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma Terminated NCT00109889 Phase 2
34 Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Terminated NCT00337506 Phase 2 Dexamethasone;velcade
35 Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies Withdrawn NCT01101412 Phase 1, Phase 2 Edetate Calcium Disodium;Ethanol;Trimethoprim-sulfamethoxazole
36 Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer Unknown status NCT00004036 Phase 1 amifostine trihydrate;carboplatin;cyclophosphamide
37 Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy Completed NCT00890747 Phase 1 sunitinib malate
38 Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction Completed NCT00025415 Phase 1 imatinib mesylate
39 PS-341 in Treating Patients With Advanced Cancer Completed NCT00006362 Phase 1 bortezomib
40 Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy Completed NCT00005634 Phase 1 vorinostat
41 Decitabine in Treating Patients With Melanoma or Other Advanced Cancer Completed NCT00002980 Phase 1 decitabine
42 Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer Completed NCT00003451 Phase 1
43 Combination Chemotherapy in Treating Patients With Advanced Cancer Completed NCT00003331 Phase 1 fluorouracil;leucovorin calcium;topotecan hydrochloride
44 Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer Completed NCT00003082 Phase 1
45 Stem Cell Transplantation in Treating Patients With Hematologic Cancer Completed NCT00004904 Phase 1 cladribine;cyclophosphamide;etoposide;methylprednisolone;tacrolimus
46 EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer Completed NCT00004258 Phase 1 cilengitide
47 Pyroxamide in Treating Patients With Advanced Cancer Completed NCT00042900 Phase 1 pyroxamide
48 Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Completed NCT00004232 Phase 1 cyclosporine;methylprednisolone;prednisone
49 Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer Completed NCT00036790 Phase 1 doxorubicin hydrochloride;motexafin gadolinium
50 Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant Active, not recruiting NCT01588015 Phase 1

Search NIH Clinical Center for Extramedullary Plasmacytoma

Genetic Tests for Extramedullary Plasmacytoma

Anatomical Context for Extramedullary Plasmacytoma

MalaCards organs/tissues related to Extramedullary Plasmacytoma:

38
Bone, Bone Marrow, Colon, Thyroid, Liver, Pancreas, Small Intestine

Publications for Extramedullary Plasmacytoma

Articles related to Extramedullary Plasmacytoma:

(show top 50) (show all 532)
# Title Authors Year
1
Extramedullary plasmacytoma: rare neoplasm of parotid gland. ( 29301803 )
2018
2
Extramedullary plasmacytoma of the testis: A case report. ( 29204364 )
2018
3
Collet-Sicard Syndrome Attributable to Extramedullary Plasmacytoma of the Jugular Foramen. ( 29191538 )
2018
4
Pattern of care and impact of prognostic factors on the outcome of head and neck extramedullary plasmacytoma: a systematic review and individual patient data analysis of 315 cases. ( 29224044 )
2018
5
Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment. ( 28507591 )
2017
6
Rare Presentation of Primary Extramedullary Plasmacytoma as Lip Lesion. ( 28409043 )
2017
7
Uterine Extramedullary Plasmacytoma as a Primary Manifestation of Multiple Myeloma. ( 28834996 )
2017
8
Extramedullary plasmacytoma occuring in ileocecum: A case report and literature review. ( 29390503 )
2017
9
Extramedullary Plasmacytoma Arising From the Anterior Mediastinum. ( 28431708 )
2017
10
Multiple Extramedullary Plasmacytoma in a Setting of Complete Bone Marrow Remission: Food for Thought. ( 29340123 )
2017
11
Extramedullary plasmacytoma in the airway of an HIV-positive child. ( 28834349 )
2017
12
Solitary Extramedullary Plasmacytoma of the Cricoid Cartilage-Case Report. ( 29230383 )
2017
13
Strategy for the treatment and follow-up of sinonasal solitary extramedullary plasmacytoma: a case series. ( 28793931 )
2017
14
Extramedullary plasmacytoma mimicking pancreatic cancer: A case report and literature review. ( 28663530 )
2017
15
Extramedullary plasmacytoma of the lateral rectus muscle. ( 28267386 )
2017
16
Management of extramedullary plasmacytoma: Role of radiotherapy and prognostic factor analysis in 55 patients. ( 29142463 )
2017
17
An extramedullary plasmacytoma in the kidney of a 14-year-old girl: Case report and review of the literature. ( 28178171 )
2017
18
Extramedullary plasmacytoma of the testicle. ( 29205163 )
2017
19
Clinical findings in 25 patients with sinonasal or nasopharyngeal extramedullary plasmacytoma in a four-decade single-centre series. ( 28537101 )
2017
20
Primary extramedullary plasmacytoma mimicking oral lichen planus. ( 28944756 )
2017
21
Oral extramedullary plasmacytoma in a HIV positive patient. ( 27894848 )
2017
22
Atrophoderma of Pasini and Pierini associated with extramedullary plasmacytoma. ( 27443586 )
2016
23
Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation. ( 27847663 )
2016
24
Retroperitoneal laparoscopic management of a solitary extramedullary plasmacytoma associated with human immunodeficiency virus infection: A case report. ( 26870281 )
2016
25
Treatment and outcomes for primary cutaneous extramedullary plasmacytoma: a case series. ( 28050154 )
2016
26
Establishment of an innovative staging system for extramedullary plasmacytoma. ( 27717354 )
2016
27
Primary Plurifocal Extramedullary Plasmacytoma of Breast. ( 27059937 )
2016
28
Extramedullary Plasmacytoma of the Paranasal Sinuses: Combining Surgery with External Radiotherapy. ( 27066407 )
2016
29
Multiple primary cutaneous plasmacytoma a decade after a nasal solitary extramedullary plasmacytoma: a puzzling case. ( 27980740 )
2016
30
Extramedullary Plasmacytoma of the Oral Cavity in a Young Man: a Case Report. ( 27284562 )
2016
31
Solitary Extramedullary Plasmacytoma of the Maxillary Sinus, Progressing to Smoldering Multiple Myeloma with Multifocal Skeletal Involvement, which Resolved Completely Following Chemotherapy Alone. ( 27408443 )
2016
32
Primary Extramedullary Plasmacytoma in the Gastroduodenal Canal Associated With Epstein-Barr Virus-Associated Adenocarcinoma of the Stomach: A Case Report. ( 27466321 )
2016
33
Solitary extramedullary plasmacytoma of the colon, rectum and anus. ( 28240504 )
2016
34
Extramedullary plasmacytoma of the gingiva. ( 26887880 )
2016
35
Double Extramedullary Plasmacytoma of the Stomach with a Long-term Endoscopic Follow-up. ( 27980257 )
2016
36
Extramedullary Plasmacytoma Presenting With Acute Airway Compromise, Treated With Emergent Rigid Bronchoscopic Resection. ( 27058726 )
2016
37
Feline Respiratory Extramedullary Plasmacytoma with Lymph Node Metastasis and Intrahistiocytic Amyloid. ( 28017340 )
2016
38
Endoscopic ultrasound-fine needle aspiration: A novel way to diagnose a solitary extramedullary plasmacytoma of the liver. ( 27080614 )
2016
39
Extramedullary Plasmacytoma of the Gallbladder Detected on Fluorine 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. ( 27761300 )
2016
40
Extramedullary Plasmacytoma of the Maxilla Simulating a Maxillary Radicular Cyst: Quick Diagnosis and Management. ( 27054435 )
2016
41
Extramedullary Plasmacytoma Diagnosed in an HIV-Positive Patient by an Unusual Clinical Presentation. ( 27980867 )
2016
42
Unusual Cause of Sphenoidal Sinus Mass: Extramedullary Plasmacytoma. ( 27779089 )
2016
43
Apparent diffusion coefficient map of a case of extramedullary plasmacytoma. ( 27200157 )
2016
44
18F-FDG PET/CT Metabolic Activity in a Patient With Solitary Extramedullary Plasmacytoma of the Lung. ( 26462042 )
2015
45
A 65-year old female with synchronous HIV and Extramedullary Plasmacytoma of Maxillary sinus. ( 26499825 )
2015
46
Solitary extramedullary plasmacytoma of thoracic epidural space presenting with dorsal compressive myelopathy: A case report and review of literature. ( 26167030 )
2015
47
Radioresistant Extramedullary Plasmacytoma of the Maxillary Sinus: A Case Report and review article. ( 26788481 )
2015
48
Extramedullary plasmacytoma associated with an ectopic tooth in the nasal cavity. ( 26535832 )
2015
49
The t(11;14)(q13;q32) Translocation as a Poor Prognostic Parameter for Autologous Stem Cell Transplantation in Myeloma Patients With Extramedullary Plasmacytoma. ( 25812994 )
2015
50
Effect of definitive radiotherapy on the long-term outcome in patients with solitary extramedullary plasmacytoma. ( 26450521 )
2015

Variations for Extramedullary Plasmacytoma

Expression for Extramedullary Plasmacytoma

Search GEO for disease gene expression data for Extramedullary Plasmacytoma.

Pathways for Extramedullary Plasmacytoma

Pathways related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

(show top 50) (show all 51)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.78 B2M BCL2 CCND1 CDKN1A IL2 IL6
2
Show member pathways
13.19 BCL2 CCND1 CDKN1A IL2 IL6
3
Show member pathways
12.91 B2M BCL2 CCND1 CDKN1A IL2 IL6
4
Show member pathways
12.85 BCL2 CCND1 CDKN1A IL6
5
Show member pathways
12.66 B2M CCND1 IL2 IL6
6
Show member pathways
12.63 BCL2 CCND1 CDKN1A IL2 IL6
7
Show member pathways
12.58 CCND1 CDKN1A IL2 IL6
8
Show member pathways
12.42 BCL2 CCND1 CDKN1A
9
Show member pathways
12.42 BCL2 IL2 IL6
10
Show member pathways
12.4 BCL2 CCND1 CDKN1A
11
Show member pathways
12.38 BCL2 CDKN1A IL2 IL6
12 12.38 BCL2 CCND1 CDKN1A IL2 IL6
13 12.34 BCL2 CCND1 CDKN1A
14
Show member pathways
12.34 BCL2 CCND1 CDKN1A IL6
15
Show member pathways
12.23 CCND1 CDKN1A IGKC
16 12.16 CCND1 CDKN1A IL2 IL6
17
Show member pathways
12.1 BCL2 CCND1 CDKN1A
18
Show member pathways
12.05 BCL2 CCND1 CDKN1A
19 12.03 CCND1 CDKN1A IL6
20 12.01 CCND1 CDKN1A IL6
21
Show member pathways
11.97 CCND1 CDKN1A IL6
22
Show member pathways
11.93 CCND1 CDKN1A IL6
23 11.91 BCL2 CCND1 CDKN1A
24 11.85 CCND1 IL2 IL6
25 11.83 BCL2 CCND1 CDKN1A
26 11.79 BCL2 CDKN1A IL6
27 11.75 BCL2 CDKN1A IL6
28 11.74 BCL2 CCND1 IL6
29
Show member pathways
11.73 BCL2 CCND1 CDKN1A IL2 IL6
30 11.7 BCL2 CCND1 CDKN1A
31 11.63 CDKN1A IL2 IL6
32 11.58 BCL2 CCND1 CDKN1A
33 11.51 BCL2 CCND1 CDKN1A IL6
34
Show member pathways
11.49 B2M IL2
35
Show member pathways
11.47 CCND1 IL2 IL6
36 11.44 BCL2 CCND1 CDKN1A
37 11.4 CCND1 CDKN1A
38 11.36 BCL2 CDKN1A
39 11.35 BCL2 CCND1 IL6
40 11.34 CCND1 CDKN1A
41 11.25 CCND1 CDKN1A IL6
42
Show member pathways
11.24 BCL2 IL2
43 11.23 CCND1 IL6
44 11.21 CCND1 IL6
45 11.18 CCND1 CDKN1A
46 11.14 IL2 IL6
47 11.08 BCL2 IL2
48 11.06 BCL2 IL2 IL6
49
Show member pathways
11 BCL2 CDKN1A
50 10.93 BCL2 IL6

GO Terms for Extramedullary Plasmacytoma

Cellular components related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cyclin-dependent protein kinase holoenzyme complex GO:0000307 8.62 CCND1 CDKN1A

Biological processes related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

(show all 22)
# Name GO ID Score Top Affiliating Genes
1 negative regulation of apoptotic process GO:0043066 9.73 BCL2 CDKN1A IL2 IL6
2 positive regulation of cell proliferation GO:0008284 9.71 BCL2 CCND1 IL2 IL6
3 immune response GO:0006955 9.67 B2M IGKC IL2 IL6
4 positive regulation of T cell proliferation GO:0042102 9.61 IL2 IL6
5 humoral immune response GO:0006959 9.6 BCL2 IL6
6 animal organ regeneration GO:0031100 9.59 CCND1 CDKN1A
7 negative regulation of G1/S transition of mitotic cell cycle GO:2000134 9.58 BCL2 CDKN1A
8 retina homeostasis GO:0001895 9.58 B2M IGKC
9 T cell differentiation GO:0030217 9.57 BCL2 IL2
10 response to organonitrogen compound GO:0010243 9.56 CCND1 CDKN1A
11 cellular response to organic substance GO:0071310 9.55 BCL2 CCND1
12 response to steroid hormone GO:0048545 9.54 BCL2 CCND1
13 extrinsic apoptotic signaling pathway in absence of ligand GO:0097192 9.52 BCL2 IL2
14 T cell differentiation in thymus GO:0033077 9.51 B2M BCL2
15 regulation of cell cycle GO:0051726 9.5 BCL2 CCND1 CDKN1A
16 response to X-ray GO:0010165 9.49 CCND1 CDKN1A
17 response to iron ion GO:0010039 9.48 BCL2 CCND1
18 response to corticosterone GO:0051412 9.46 CCND1 CDKN1A
19 response to drug GO:0042493 9.46 B2M BCL2 CCND1 CDKN1A
20 positive regulation of immunoglobulin secretion GO:0051024 9.26 IL2 IL6
21 positive regulation of B cell proliferation GO:0030890 9.13 BCL2 CDKN1A IL2
22 response to glucocorticoid GO:0051384 8.92 BCL2 CCND1 CDKN1A IL6

Molecular functions related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cyclin-dependent protein serine/threonine kinase activity GO:0004693 8.62 CCND1 CDKN1A

Sources for Extramedullary Plasmacytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....